Adalimumab/infliximab Reactions 1680, p17 - 2 Dec 2017 Sarcoidosis-like lesions (a paradoxical reaction to anti-tumour necrosis factor) and uveitis: 2 case reports In a case series, a 30-year-old man developed sarcoidosis like lesions and uveitis during treatment with adalimumab, and a 21-year-old man developed sarcoidosis like lesions during treatment with adalimumab and infliximab [dosages and routes not stated]. Case 1: A 30-year-old man, who had been diagnosed with Crohn’s disease (CD) at the age of 17, was started on infliximab; however, the drug was stopped due to a paradoxical psoriasiform reaction. Three months later, he was started on adalimumab for a serious CD relapse. After more than five years of treatment, he developed a bilateral intermediate uveitis with an anterior component. Differential diagnosis included an infection, CD-related uveitis and adalimumab-induced uveitis. Adalimumab was stopped. Five months later, he presented with significant weight loss, fatigue, increased stool frequency and urgency. A CT scan of chest and abdomen revealed bilateral mediastinal and hilar lymphadenopathies, as well as multiple nodular lung lesions, an enlarged spleen and multiple mesenterial lymphadenopathies. Blood analysis revealed a C-reactive protein of 15 mg/L and an angiotensin-converting enzyme of 78 U/L. Histology revealed non-necrotising granulomas. Positron emission tomography combined with CT-scan revealed hypermetabolic lung lesions, multiple lymphadenopathies and elevated tracer uptake in rectum and sigmoid. Finally, he was diagnosed with a novel onset sarcoidosis in combination with active CD. He was treated with methylprednisolone. Two months later, his condition improved. Case 2: A 21-year-old man, who had been diagnosed with CD at the age of 10, was started on treatment with infliximab for 6 years. Later, the therapy was switched to adalimumab due to a delayed hypersensitivity reaction. Eighteen months later, he presented with a nodular skin lesion. Biopsy showed a non-caseating granulomatous inflammatory process. A chest X-ray showed hilar lymphadenopathies. High-resolution CT confirmed above findings and showed mediastinal lymphadenopathies and multiple small nodules. Laboratory analysis showed elevation of ACE. Therefore, adalimumab was stopped. Serum analysis did not detect adalimumab. Finally, he was diagnosed with sarcoidosis-like lesions. Therefore, he was treated with topical steroids and hydroxychloroquine. Four months after corrective treatment, he showed a deterioration of lung function tests. Furthermore, magnetic resonance imaging suggested cardiac involvement. He was treated with high doses methylprednisolone. After one month, an improvement was noted in cutaneous lesions and lung function test results. Author comment: "We reported two cases of sarcoidosis- like lesions, which developed during or shortly after [anti- tumour necrosis factor] treatment for CD. The development of sarcoidosis-like lesions during anti-TNF therapy can be seen as paradoxical since some anti-TNF agents are also used in refractory sarcoidosis" Decock A, et al. Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti- TNF Therapy?. [Review]. Journal of Crohn’s and Colitis 11: 378-383, No. 3, 30 Sep 2016. Available from: URL: - Belgium 803284688 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial